PLASMA CITRATE IS ELEVATED IN SUBJECTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND IS ASSOCIATED WITH LIVER FIBROSIS

被引：0
|
作者：
Garcia, Erwin [1 ]
Shalaurova, Irina [1 ]
Jiang, Z. Gordon [2 ,3 ]
Lai, Michelle [4 ]
Connelly, Margery [1 ]
机构：
[1] Labcorp, Burlington, NC USA
[2] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA
[3] Beth Israel Deaconess Med Ctr, Div Gastroenterol & Hepatol, Boston, MA 02215 USA
[4] Harvard Med Sch, Div Gastroenterol & Hepatol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA
来源：
HEPATOLOGY | 2021年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1633
引用
收藏
页码：977A / 978A
页数：2
相关论文
共 50 条
  • [31] NONINVASIVE LIVER FIBROSIS TESTS PERFORMANCE IN MORBIDLY OBESE PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Golabi, Pegah
    Paik, James
    de Avila, Leyla
    Noor, Sohailla
    Nader, Samir
    Younossi, Zobair M.
    GASTROENTEROLOGY, 2020, 158 (06) : S1406 - S1406
  • [32] COMPARISON OF NAFLD FIBROSIS SCORE AND BARD SCORE IN PREDICTING FIBROSIS IN NONALCOHOLIC FATTY LIVER DISEASE
    Ruffillo, Gabriela E.
    Fassio, Eduardo
    Alvarez, Estela
    Landeira, Graciela
    Longo, Cristina G.
    Dominguez, Nora
    Gualano, Gisela
    HEPATOLOGY, 2009, 50 (04) : 782A - 782A
  • [33] Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease
    Ruffillo, Gabriela
    Fassio, Eduardo
    Alvarez, Estela
    Landeira, Graciela
    Longo, Cristina
    Dominguez, Nora
    Gualano, Gisela
    JOURNAL OF HEPATOLOGY, 2011, 54 (01) : 160 - 163
  • [34] DISCORDANCY IN FIBROSIS SCORE ON FIBROSCAN COMPARED WITH LIVER BIOPSY AND ITS RELATIONSHIP TO FATTY LIVER DISEASE IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) PATIENTS
    Mitchell, Brittany
    Fahad, Hamna
    Sarmini, Muhammad Talal
    McCullough, Arthur
    GASTROENTEROLOGY, 2020, 158 (06) : S1410 - S1411
  • [35] Pathologic features associated with fibrosis in nonalcoholic fatty liver disease
    Gramlich, T
    Kleiner, DE
    McCullough, AJ
    Matteoni, CA
    Boparai, N
    Younossi, ZM
    HUMAN PATHOLOGY, 2004, 35 (02) : 196 - 199
  • [36] The clinical and pathological spectrum of nonalcoholic fatty liver liver disease (NAFLD)
    Copaci, I
    Voiculescu, M
    Micu, L
    Hortopan, M
    Cojocaru, L
    JOURNAL OF HEPATOLOGY, 2002, 36 : 255 - 255
  • [37] Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis
    Younossi, Zobair M.
    Loomba, Rohit
    Anstee, Quentin M.
    Rinella, Mary E.
    Bugianesi, Elisabetta
    Marchesini, Giulio
    Neuschwander-Tetri, Brent A.
    Serfaty, Lawrence
    Negro, Francesco
    Caldwell, Stephen H.
    Ratziu, Vlad
    Corey, Kathleen E.
    Friedman, Scott L.
    Abdelmalek, Manal F.
    Harrison, Stephen A.
    Sanyal, Arun J.
    Lavine, Joel E.
    Mathurin, Philippe
    Charlton, Michael R.
    Goodman, Zachary D.
    Chalasani, Naga P.
    Kowdley, Kris V.
    George, Jacob
    Lindor, Keith
    HEPATOLOGY, 2018, 68 (01) : 349 - 360
  • [38] Noninvasive Diagnostics in Nonalcoholic Fatty Liver Disease (NAFLD)
    Stauber R.
    Journal für Gastroenterologische und Hepatologische Erkrankungen, 2019, 17 (3) : 75 - 81
  • [39] Developmental Origins of Nonalcoholic Fatty Liver Disease (NAFLD)
    Itoh, Hiroaki
    Kanayama, Naohiro
    DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE (DOHAD): FROM BIOLOGICAL BASIS TO CLINICAL SIGNIFICANCE, 2018, 1012 : 29 - 39
  • [40] An endocrine perspective of nonalcoholic fatty liver disease (NAFLD)
    Lomonaco, Romina
    Chen, Janet
    Cusi, Kenneth
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2011, 2 (05) : 211 - 225
12345